Better Medicine, Together
A Product Development Organization partnering across discovery, preclinical, and clinical development, powered by proprietary AI, real-world data, and tech-enabled services across multiple modalities.
Building a PDO to deliver the infrastructure behind the next generation of therapeutics.
We partner with biotech innovators, pharma, academic founders, and sovereign organizations worldwide, combining proprietary AI, real-world data, and an integrated platform spanning discovery through clinical development to help bring better medicines to patients, faster.
Discover our platforms and services
AI/ML
Accelerating discovery with Alloy’s integrated AI/ML
Alloy Therapeutics embeds AI/ML directly into the core of our discovery and development platforms, uniting predictive modeling with a global wet-lab engine to drive real biological outcomes. Trained on one of the industry’s largest proprietary experimental datasets, our models shorten design cycles, improve prediction accuracy, and enable teams to rapidly move from concept to human data with speed, precision, and capital efficiency.
Antibodies & Multispecifics
AI/ML powered end-to-end discovery services and proprietary platforms
We put AI/ML at the center of antibody and bispecific discovery —streamlining campaigns from design to IND. Our in vivo platforms, generative modeling, and in silico developability tools work together to rapidly produce high-quality, de-risked candidates ready for downstream development.
TCR Mimics
Unlock new targets with TCRms
TCRm antibodies mimic the function of T-cell receptors by targeting intracellular peptides presented on cell surface MHC complexes (pMHC), opening up a wide range of intracellular targets in oncology and infectious disease. Keyway™ TCRm discovery is the first fully integrated platform and service, combining our world-class antibody discovery expertise with the pioneers of TCR therapeutics.
Genetic medicines
Empowering breakthroughs with Alloy’s antisense platform
Alloy Therapeutics integrates AI/ML with foundational antisense technologies to overcome the therapeutic index and delivery barriers that have historically limited ASO drug candidates. Collaborate with us to rapidly refine existing sequences or design de novo molecules in our Anticlastic™ format—a transiently cyclized structure engineered for improved potency, safety, and scalability.
Pharmacology
High-Insight Pharmacology Through Strategic Partnership and Global Efficiency
82VS
Building the most efficient companies with a unique venture approach
Creating asset centric drug companies with incredible capital efficiency by leveraging the platforms and services of Alloy Therapeutics.
Spannerwerks
Advancing programs from candidate into the clinic with expertise and efficiency
Spannerwerks provides hands-on development support across core drug development functions, helping biotech teams execute with focus, flexibility, and confidence through early development milestones.
Connect with us at upcoming events
Collaboration among scientists, competition against disease
We collaborate with our partners to leverage the full potential of our technology and services, acting as an innovation engine for the drug discovery industry.
